{
    "eid": "2-s2.0-85042518674",
    "title": "The comparative value of feline virology research: Can findings from the feline lentiviral vaccine be translated to humans?",
    "cover-date": "2017-03-01",
    "subject-areas": [
        {
            "$": "General Veterinary",
            "@code": "3400"
        }
    ],
    "keywords": [
        "Comparative study",
        "Feline immunodeficiency virus",
        "Human immunodeficiency virus",
        "Tropism",
        "Vaccine"
    ],
    "authors": [
        "Margaret J. Hosie"
    ],
    "citedby-count": 6,
    "ref-count": 63,
    "ref-list": [
        "FIV infection of the domestic cat: An animal model for AIDS",
        "Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen",
        "FIV in cats - a useful model of HIV in people?",
        "Vaccination of cats against feline immunodeficiency virus (FIV): A matter of challenge",
        "Efficacy evaluation of prime-boost protocol: Canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats",
        "Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats",
        "Effect of dual-subtype vaccine against feline immunodeficiency virus infection",
        "FIV vaccine development and its importance to veterinary and human medicine: A review: FIV vaccine 2002 update and review",
        "Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates",
        "Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats",
        "Feline leukemia and feline immunodeficiency virus in Canada - A comment",
        "Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge",
        "Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review",
        "HIV/AIDS vaccines: 2007",
        "Human immunodeficiency virus-1 vaccine design: Where do we go now",
        "Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection",
        "Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial",
        "Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand",
        "Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial",
        "HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis",
        "Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand",
        "Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)",
        "Limited efficacy of an inactive feline immunodeficiency virus vaccine",
        "Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine",
        "The protective rate of the feline immunodeficiency virus vaccine: An Australian field study",
        "Use of CD134 As a Primary Receptor by the Feline Immunodeficiency Virus",
        "Common mechanism of infection by lentiviruses",
        "Development of clinical disease in cats experimentally infected with feline immunodeficiency virus",
        "Pathogenesis of HIV infection: What the virus spares is as important as what it destroys",
        "Selective transmission of CCR5-utilizing HIV-1: The 'gatekeeper' problem resolved?",
        "The HIV coreceptor switch: A population dynamical perspective",
        "Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus",
        "Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus",
        "Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus",
        "Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody",
        "Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus",
        "Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (OX40) ligand",
        "Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage",
        "Serological responses of cats to feline immunodeficiency virus",
        "Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate",
        "Molecularly cloned feline immunodeficiency virus NCSU JSY3 induces immunodeficiency in specific-pathogen-free cats",
        "Feline immunodeficiency virus env gene evolution in experimentally infected cats",
        "Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats",
        "Selective Expansion of Viral Variants following Experimental Transmission of a Reconstituted Feline Immunodeficiency Virus Quasispecies",
        "Investigating the Role of Target Cell Availability in the Pathogenesis of Feline Immunodeficiency Virus Infection",
        "Change in coreceptor use correlates with disease progression in HIV-1- infected individuals",
        "Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus",
        "AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts",
        "Enhancement after feline immunodeficiency virus vaccination",
        "Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope",
        "Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines",
        "Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection",
        "In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus",
        "Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein",
        "Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein",
        "Accelerated viraemia in cats vaccinated with fixed autologous FIV- infected cells",
        "Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus",
        "Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement",
        "Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction",
        "Enhancement of Infectivity of a Non\u2010Syncytium Inducing HIV\u20101 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV\u20101",
        "Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies",
        "The Role of Virus Neutralisation in Immunity to Feline Immunodeficiency Virus Infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Glasgow",
            "affilname": "University of Glasgow",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Petplan Charitable Trust",
        "Wellcome Trust",
        "Medical Research Council"
    ]
}